drugset / Trial / NCT02485067
Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to assess the efficacy and safety of THVD-201(Combination of tolterodine and pilocarpine) in patients with Overactive bladder during the period of treatment, 12 weeks. This study also includes an open label extension period of an additional 12 weeks following the treatment to assess long-term efficacy and safety of THVD-201 in patients with Overactive bladder.
Timeline
- Start
- 2015-01
- Primary completion
- 2016-07
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pilocarpine | Unknown | 9 mg | — |
| Comparator | Tolterodine | Small molecule | 2 mg | — |